Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with type 2 diabetes. While some GLP-1 agonists are used for weight loss in ...

Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the skin.

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes and reduce certain heart risks. Its mechanism of action is mimicking a natural hormone (GLP-1) that manages your blood ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades.

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.

liraglutide (marketed as Victoza), will impact the blood sugar levels of teenage and young adult type 1 diabetic patients currently treated with insulin alone. The researchers are currently recruiting ...

Victoza, Ozempic and Rybelsus accounted for DKr33.2bn in revenue and Saxenda DKr5.7bn. With DKr4.2bn of other diabetes drugs, the diabetes total was DKr102.8bn. Throw in revenue of DKr19.2bn at ...